Striving Towards EmPowerment and Medication Adherence (STEP-AD)

NACompletedINTERVENTIONAL
Enrollment

184

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

December 1, 2019

Study Completion Date

December 1, 2019

Conditions
HIV
Interventions
BEHAVIORAL

Experimental Intervention (STEP-AD)

This experimental intervention will consist of 10 sessions- 1 session of Lifesteps (problem solving for medication adherence) and 9 sessions of an intervention specifically tailored for Black women living with HIV to address trauma/abuse, racial discrimination, HIV stigma, and gender roles expectations in order to improve health outcomes (e.g., medication adherence, viral load), increase resiliency, and enhance adaptive coping strategies.

BEHAVIORAL

Enhanced Treatment as Usual (E-TAU)

Participants assigned to the E-TAU condition will receive 1 session of Lifesteps (problem solving for medication adherence) and appropriate services and referrals as needed

Trial Locations (2)

33136

University of Miami, Miami

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
collaborator

Massachusetts General Hospital

OTHER

collaborator

National Institute of Mental Health (NIMH)

NIH

lead

University of Miami

OTHER

NCT02764853 - Striving Towards EmPowerment and Medication Adherence (STEP-AD) | Biotech Hunter | Biotech Hunter